HIMS: Hims & Hers Health, Inc. Stock

SIC 8011 – Offices and Clinics of Doctors of Medicine

Valuation
Market Cap ($M) 2,658.85
Enterprise Value ($M) 2,562.18
Book Value ($M) 344.03
Book Value / Share 1.61
Price / Book 7.73
NCAV ($M) 167.90
NCAV / Share 0.78
Price / NCAV 15.84

Profitability (mra)
Return on Invested Capital (ROIC) -0.07
Return on Assets (ROA) -0.06
Return on Equity (ROE) -0.08

Liquidity (mrq)
Quick Ratio 2.74
Current Ratio 3.00

Balance Sheet (mrq) ($M)
Current Assets 265.05
Assets 441.19
Liabilities 97.16
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 872.00
Operating Income -26.44
Net Income -23.55
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 73.48
Cash from Investing -12.11
Cash from Financing -11.47

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-29 13D/A Institutional Venture Management XVI, LLC 6.20 -18.32
02-14 13G/A Abraham Jack 4.60 -21.93
02-13 13G/A Vanguard Group Inc 6.96 25.20
01-31 13G BlackRock Inc. 5.30
06-02 13G/A NewView Capital Fund I, L.P. 2.00 -73.26

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-02-26 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTI
2023-11-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended September 30, 2023 ☐ TRANSITION REPORT PURSUANT
2023-08-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended June 30, 2023 ☐ TRANSITION REPORT PURSUANT TO S
2023-05-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended March 31, 2023 ☐ TRANSITION REPORT PURSUANT TO

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-19 457,882 4,223,894 10.84
2024-04-18 591,367 3,110,839 19.01
2024-04-17 346,787 3,898,714 8.89
2024-04-16 1,379,641 7,022,686 19.65
2024-04-15 1,071,371 5,292,525 20.24

(click for more detail)

Similar Companies
TDOC – Teladoc Health, Inc.


Financial data and stock pages provided by
Fintel.io